Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate panel bars use of state funds to buy opioid reversal drugs from companies tied to opioid litigation
Summary
Senators voted to prohibit state funds and certain contracts from being used to purchase opioid antagonists from manufacturers that were party to the opioid crisis, arguing the state should not reward firms that helped cause opioid harms. The measure passed 49-1 on second reading.
Senate Bill 112, carried by Senator Yakovich, passed the Committee of the Whole on second reading by a 49-1 vote, prohibiting state funds (and available federal funds except as provided) from being used after June 30, 2025, to purchase opioid antagonists from a manufacturer or an affiliate that was a party to settlements or litigation tied to the opioid crisis.
Sponsor Yakovich said the bill…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
